Sullivan, Bruyette, Speros & Blaney’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$115K Sell
307
-352
-53% -$144K 0.01% 393
2020
Q4
$237K Buy
659
+3
+0.5% +$956 0.01% 256
2020
Q3
$197K Hold
656
0.01% 252
2020
Q2
$236K Hold
656
0.01% 214
2020
Q1
$174K Hold
656
0.01% 224
2019
Q4
$212K Hold
656
0.01% 242
2019
Q3
$194K Hold
656
0.01% 241
2019
Q2
$235K Buy
+656
New +$207K 0.01% 210

Other funds holding ILMN

Sullivan, Bruyette, Speros & Blaney's ILMN Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its Illumina (ILMN) stake by 53% in Q1 2021, selling an estimated $144K and leaving 307 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #393.

Sullivan, Bruyette, Speros & Blaney first reported a position in ILMN in Q2 2019 and has held it in 8 quarters since. The position peaked at $237K in Q4 2020. 1,047 funds tracked by Wall St. Rank hold ILMN as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 307 shares of Illumina worth $115K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 352 Illumina shares in Q1 2021, an estimated $144K.
  • Illumina made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #393 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Illumina in Q2 2019 and has held it in 8 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Illumina position peaked at $237K in Q4 2020.
  • 1,047 funds tracked by Wall St. Rank held Illumina as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.